These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6046257)

  • 21. Brain aluminum distribution in Alzheimer's disease and experimental neurofibrillary degeneration.
    Crapper DR; Krishnan SS; Dalton AJ
    Trans Am Neurol Assoc; 1973; 98():17-20. PubMed ID: 4784929
    [No Abstract]   [Full Text] [Related]  

  • 22. Neurochemical characteristics of aluminum-induced neurofibrillary degeneration in rabbits.
    Beal MF; Mazurek MF; Ellison DW; Kowall NW; Solomon PR; Pendlebury WW
    Neuroscience; 1989; 29(2):339-46. PubMed ID: 2566953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progressing encephalomyelopathy with muscular atrophy, induced by aluminum powder.
    Bugiani O; Ghetti B
    Neurobiol Aging; 1982; 3(3):209-22. PubMed ID: 7162550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholinergic enzymes in neurofibrillary degeneration produced by aluminium.
    Yates CM; Simpson J; Russell D; Gordon A
    Brain Res; 1980 Sep; 197(1):269-74. PubMed ID: 7397560
    [No Abstract]   [Full Text] [Related]  

  • 25. Role of proteasomes in the formation of neurofilamentous inclusions in spinal motor neurons of aluminum-treated rabbits.
    Kimura N; Kumamoto T; Ueyama H; Horinouchi H; Ohama E
    Neuropathology; 2007 Dec; 27(6):522-30. PubMed ID: 18021372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversal by desferrioxamine of tau protein aggregates following two days of treatment in aluminum-induced neurofibrillary degeneration in rabbit: implications for clinical trials in Alzheimer's disease.
    Savory J; Huang Y; Wills MR; Herman MM
    Neurotoxicology; 1998 Apr; 19(2):209-14. PubMed ID: 9553957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study on the experimentally produced changes in the neurofibrils in animals, with special reference to electron microscopy findings].
    Ikuta F; Oyanagi S; Tanaka M
    Shinkei Kenkyu No Shimpo; 1968 Dec; 12(4):897-907. PubMed ID: 4980044
    [No Abstract]   [Full Text] [Related]  

  • 28. [Experimental neurofibrillary change induced by aluminum lactate].
    Mori H; Nakamura H; Wakuani K
    Shinkei Kenkyu No Shimpo; 1969 Jun; 13(2):279-90. PubMed ID: 5390674
    [No Abstract]   [Full Text] [Related]  

  • 29. Neuronal correlates of an encephalopathy associated with aluminum neurofibrillary degeneration.
    Crapper DR; Tomko GJ
    Brain Res; 1975 Oct; 97(2):253-64. PubMed ID: 1236766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic model of neurofibrillary changes induced in mature rabbits by metallic aluminum.
    Wisniewski HM; Sturman JA; Shek JW
    Neurobiol Aging; 1982; 3(1):11-22. PubMed ID: 7099362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High affinity uptake of GABA and glycine by rabbits with aluminum-induced neurofibrillary changes.
    Sturman JA; Wisniewski HM; Shek JW
    Neurochem Res; 1983 Sep; 8(9):1097-109. PubMed ID: 6633788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The rabbit retina: a long-term model system for aluminum-induced neurofibrillary degeneration.
    Fry KR; Edwards DM; Shaw KA; Watt CB
    Neurosci Lett; 1991 Apr; 124(2):216-20. PubMed ID: 2067721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental aluminum encephalomyelopathy. Relationship to human neurodegenerative disease.
    Rao JK; Katsetos CD; Herman MM; Savory J
    Clin Lab Med; 1998 Dec; 18(4):687-98, viii. PubMed ID: 9891607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurofibrillary axonal pathology in aluminum intoxication.
    Troncoso JC; Price DL; Griffin JW; Parhad IM
    Ann Neurol; 1982 Sep; 12(3):278-83. PubMed ID: 7137964
    [No Abstract]   [Full Text] [Related]  

  • 35. Aluminum inhibition of ADP-ribosylation in vivo and in vitro.
    McLachlan DR; Dam TV; Farnell BJ; Lewis PN
    Neurobehav Toxicol Teratol; 1983; 5(6):645-7. PubMed ID: 6422319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aluminum induced neurofibrillary degeneration, brain electrical activity and alterations in acquisition and retention.
    Crapper DR; Dalton AJ
    Physiol Behav; 1973 May; 10(5):935-45. PubMed ID: 4736728
    [No Abstract]   [Full Text] [Related]  

  • 37. Neuronal changes induced by intrathecal vincristine sulfate.
    Schochet SS; Lampert PW; Earle KM
    J Neuropathol Exp Neurol; 1968 Oct; 27(4):645-58. PubMed ID: 5696051
    [No Abstract]   [Full Text] [Related]  

  • 38. EXPERIMENTAL PRODUCTION OF NEUROFIBRILLARY DEGENERATION. I. LIGHT MICROSCOPIC OBSERVATIONS.
    KLATZO I; WISNIEWSKI H; STREICHER E
    J Neuropathol Exp Neurol; 1965 Apr; 24():187-99. PubMed ID: 14280496
    [No Abstract]   [Full Text] [Related]  

  • 39. Progressive dialysis encephalopathy. Role of aluminum toxicity.
    Poisson M; Mashaly R; Lafforgue B
    Ann Neurol; 1979 Jul; 6(1):88. PubMed ID: 507770
    [No Abstract]   [Full Text] [Related]  

  • 40. [The most important human aluminoses].
    Avtsyn AP
    Arkh Patol; 1986; 48(5):3-11. PubMed ID: 3090983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.